OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
PharmSource Information Services
Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.
August 01, 2018
Heightened uncertainty means CDMO executives need to play out planning scenarios.
May 02, 2018
CDMOs can claim credit for the robust growth of emerging bio/pharma financings.
January 02, 2018
The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.
November 02, 2017
Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.
Acquisition activity has created some CDMOs with facilities and capabilities that rivals global bio/pharma companies.
November 01, 2017
Investors are betting on the current growth of CDMOs; but history reminds us that extrapolating today’s market well into the future is dangerous.